Yue-min Nan

139 Ziqiang Road
Shijiazhuang, 050051, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Development of anticirrhotic drugs from the perspective of the fatty acid metabolism-immune axis: Taking Fuzheng Huayu tablet as an example.

Development of anticirrhotic drugs from the perspective of the fatty acid metabolism-immune axis: Taking Fuzheng Huayu tablet as an example.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: May 06, 2026

Molecular mechanisms of FSP1-regulated ferroptosis and therapeutic implications in various cancers.

Molecular mechanisms of FSP1-regulated ferroptosis and therapeutic implications in various cancers.

Journal: Cellular & molecular biology letters

Published: February 05, 2026

Correction: Heme oxygenase-1 prevents non-alcoholic steatohepatitis through suppressing hepatocyte apoptosis in mice.

Correction: Heme oxygenase-1 prevents non-alcoholic steatohepatitis through suppressing hepatocyte apoptosis in mice.

Journal: Lipids in health and disease

Published: December 24, 2025

Targeting the MIR4435-2HG/miR-29c-3p/FSP1 axis overcomes lenvatinib resistance by inducing ferroptosis in hepatocellular carcinoma.

Targeting the MIR4435-2HG/miR-29c-3p/FSP1 axis overcomes lenvatinib resistance by inducing ferroptosis in hepatocellular carcinoma.

Journal: Cancer cell international

Published: October 13, 2025

Intracellular IL-24 ameliorates lipid metabolic disorders in metabolic dysfunction-associated steatohepatitis by restoring the autophagy-lysosome pathway.

Intracellular IL-24 ameliorates lipid metabolic disorders in metabolic dysfunction-associated steatohepatitis by restoring the autophagy-lysosome pathway.

Journal: Cellular and molecular life sciences : CMLS

Published: July 12, 2025

Impact of Chronic Hepatitis B and Its Clinical Phases on Liver Fibrosis and Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Impact of Chronic Hepatitis B and Its Clinical Phases on Liver Fibrosis and Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: July 08, 2025

LEAST as a novel prediction model of hepatocellular carcinoma development in patients with chronic hepatitis B: a multi-center study.

LEAST as a novel prediction model of hepatocellular carcinoma development in patients with chronic hepatitis B: a multi-center study.

Journal: BMC medicine

Published: May 12, 2025

Combining transcriptomics with network pharmacology to explore the mechanism of Yiqi Huoxue decoction against liver fibrosis.

Combining transcriptomics with network pharmacology to explore the mechanism of Yiqi Huoxue decoction against liver fibrosis.

Journal: PloS one

Published: January 16, 2025

Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024).

Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024).

Journal: Journal of clinical and translational hepatology

Published: August 28, 2024

Identification and validation of plasma AGRN as a novel diagnostic biomarker of hepatitis B Virus-related chronic hepatitis and liver fibrosis/cirrhosis.

Identification and validation of plasma AGRN as a novel diagnostic biomarker of hepatitis B Virus-related chronic hepatitis and liver fibrosis/cirrhosis.

Journal: Histology and histopathology

Published: January 10, 2024

Combined DeRitis ratio and alkaline phosphatase on the prediction of portal vein tumor thrombosis in patients with hepatocellular carcinoma.

Combined DeRitis ratio and alkaline phosphatase on the prediction of portal vein tumor thrombosis in patients with hepatocellular carcinoma.

Journal: Scientific reports

Published: October 23, 2023

Heme oxygenase 1 alleviates nonalcoholic steatohepatitis by suppressing hepatic ferroptosis.

Heme oxygenase 1 alleviates nonalcoholic steatohepatitis by suppressing hepatic ferroptosis.

Journal: Lipids in health and disease

Published: March 09, 2023

Showing 1-12 of 60

Last Updated: 09/26/2026